Literature DB >> 21119569

Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats.

Silvio A Oliveira Junior1, Maeli Dal Pai-Silva, Paula F Martinez, Ana P Lima-Leopoldo, Dijon H S Campos, André S Leopoldo, Marina P Okoshi, Katashi Okoshi, Carlos R Padovani, Antonio C Cicogna.   

Abstract

BACKGROUND: Although obesity has been associated with several effects in rodents, few investigations have evaluated the metabolic, endocrine, and cardiac parameters of spontaneously hypertensive rats (SHR) with dietary-induced obesity. The current study analyzed the influence of dietary-induced obesity on metabolic, endocrine, and cardiac characteristics in SHR. MATERIAL/
METHODS: Male SHR were distributed in 2 groups: C-SHR (n=10) and OB-SHR (n=10). While C-SHR received a standard commercial diet (CD; 3.2 kcal/g), OB-SHR were submitted to a hypercaloric diet (HD; 4.6 kcal/g) for 20 weeks. Nutritional, metabolic, and endocrine evaluation involved measurement of calorie intake, dietary efficiency, body weight, adiposity, glycemia, triacylglycerol, insulin, and leptin. Cardiovascular evaluation integrated systolic blood pressure (SBP), echocardiography, gross and ultrastructural morphology, and myosin heavy chain (MHC) analyses of the myocardium.
RESULTS: Animals in OB-SHR had greater values of BW, adiposity, triacylglycerol, and leptin and impaired glycemic tolerance compared with the C-SHR group. In the cardiovascular context, dietary-induced obesity increased interstitial collagen, the cardiomyocyte area, and the relative expression of beta-MHC, and well as beta-/alpha-isoform ratio of MHC. Likewise, OB-SHR showed ultrastructural morphologic alterations, with loss and disorganization of myofilaments, lipid droplets, severe mitochondrial damage, and T-tubule dilation. Concerning the in-vivo cardiovascular profile, although SBP and systolic function were unchanged by dietary-induced obesity, echocardiography results evidenced impaired diastolic function in OB-SHR in relation to their control counterparts.
CONCLUSIONS: Diet-induced obesity was associated with endocrine alterations, and it accentuated cardiac remodeling, promoting diastolic dysfunction of restrictive filling pattern in the SHR strain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119569

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  22 in total

1.  Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.

Authors:  Zi-Lun Li; John R Woollard; Behzad Ebrahimi; John A Crane; Kyra L Jordan; Amir Lerman; Shen-Ming Wang; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

2.  Effects of two aerobic exercise training protocols on parameters of oxidative stress in the blood and liver of obese rats.

Authors:  Daniela Delwing-de Lima; Ariene Sampaio Souza Farias Ulbricht; Carla Werlang-Coelho; Débora Delwing-Dal Magro; Victor Hugo Antonio Joaquim; Eloise Mariani Salamaia; Silvana Rodrigues de Quevedo; Larissa Desordi
Journal:  J Physiol Sci       Date:  2017-12-08       Impact factor: 2.781

3.  Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET.

Authors:  Fatiha Maskali; Sylvain Poussier; Huguette Louis; Henri Boutley; Mickael Lhuillier; Simon N Thornton; Gilles Karcher; Patrick Lacolley; Pierre Y Marie
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-03       Impact factor: 2.357

4.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

5.  Prevalence and predictors of ventricular remodeling after anterior myocardial infarction in the era of modern medical therapy.

Authors:  Elaine Farah; Ana Lucia Cogni; Marcos F Minicucci; Paula S Azevedo; Katashi Okoshi; Beatriz B Matsubara; Silméia G Zanati; Rodrigo Haggeman; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Med Sci Monit       Date:  2012-05

6.  Sex-specific association of anthropometric measures of body composition with arterial stiffness in a healthy population.

Authors:  Danijela Budimir; Ana Jeroncic; Grgo Gunjaca; Igor Rudan; Ozren Polasek; Mladen Boban
Journal:  Med Sci Monit       Date:  2012-02

7.  The importance of the presence of aggregatibacter actinomycetemcomitans in sulcus gingivalis of patients with cardiovascular diseases.

Authors:  Michal Straka; Jan Kazar; Michal R Pijak; Jan Gasparovic; Ladislava Wsolova; Viera Mongiellova
Journal:  Med Sci Monit       Date:  2011-11

8.  Aerobic Exercise During Advance Stage of Uncontrolled Arterial Hypertension.

Authors:  Luana U Pagan; Mariana J Gomes; Ricardo L Damatto; Aline R R Lima; Marcelo D M Cezar; Felipe C Damatto; David R A Reyes; Dijon H S Campos; Tulio M M Caldonazo; Bertha F Polegato; Denise C Fernandes; Francisco R Laurindo; Ana A H Fernandes; Ana Lloret; Antonio C Cicogna; Marina P Okoshi; Katashi Okoshi
Journal:  Front Physiol       Date:  2021-06-03       Impact factor: 4.566

9.  Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats.

Authors:  Dominik Linz; Mathias Hohl; Felix Mahfoud; Jan-Christian Reil; Wolfgang Linz; Thomas Hübschle; Hans-Paul Juretschke; Claudia Neumann-Häflin; Hartmut Rütten; Michael Böhm
Journal:  J Transl Med       Date:  2012-09-10       Impact factor: 5.531

10.  Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats.

Authors:  Kimberly M Jeckel; D N Rao Veeramachaneni; Adam J Chicco; Phillip L Chapman; Christopher M Mulligan; Jennifer R Hegarty; Michael J Pagliassotti; Lindsay A Ferguson; Gerrit J Bouma; Melinda A Frye
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.